141 related articles for article (PubMed ID: 6398549)
21. Syntheses and biological activities of some prostacyclin analogs.
Ohuchida S; Hashimoto S; Wakatsuka H; Arai Y; Hayashi M
Adv Prostaglandin Thromboxane Res; 1980; 6():337-40. PubMed ID: 6992532
[No Abstract] [Full Text] [Related]
22. Preservation of platelets and their function in prolonged cardiopulmonary bypass using prostacyclin.
Koshal A; Krausz MM; Utsunomiya T; Hechtman HB; Collins JJ; Cohn LH
Circulation; 1981 Aug; 64(2 Pt 2):II44-8. PubMed ID: 7018736
[TBL] [Abstract][Full Text] [Related]
23. Pilot study of the effects of taprostene (CG 4203) in patients with advanced peripheral arterial disease.
Darius H; Kopp H; Mulfinger A; Spielberger M; Todt M; Schuster CJ; Meyer J
Prog Clin Biol Res; 1989; 301():417-21. PubMed ID: 2508112
[No Abstract] [Full Text] [Related]
24. [Possibility of improvement of new cardiopulmonary bypass technique without heparin].
Tanabe T; Sakai K; Matsukura H; Takeda H; Goda T; Edazawa H; Uzawa S
Kyobu Geka; 1984 Feb; 37(2):106-11. PubMed ID: 6371343
[No Abstract] [Full Text] [Related]
25. Attenuation of ischemic liver injury by prostaglandin E1 analogue, misoprostol, and prostaglandin I2 analogue, OP-41483.
Totsuka E; Todo S; Zhu Y; Ishizaki N; Kawashima Y; Jin MB; Urakami A; Shimamura T; Starzl TE
J Am Coll Surg; 1998 Sep; 187(3):276-86. PubMed ID: 9740185
[TBL] [Abstract][Full Text] [Related]
26. Ro 44-9883, a new nonpeptide glycoprotein IIb/IIIa antagonist, prevents platelet loss during experimental cardiopulmonary bypass.
Carteaux JP; Roux S; Kuhn H; Tschopp T; Colombo V; Hadváry P
J Thorac Cardiovasc Surg; 1993 Nov; 106(5):834-41. PubMed ID: 8231205
[TBL] [Abstract][Full Text] [Related]
27. The antiplatelet activity of immobilized prostacyclin.
Ebert CD; Lee ES; Kim SW
J Biomed Mater Res; 1982 Sep; 16(5):629-38. PubMed ID: 6752148
[TBL] [Abstract][Full Text] [Related]
28. [Surveillance of treatment with antiaggregating agents].
Cauchie C
Rev Med Brux; 1983 Jan; 4(1):34-8. PubMed ID: 6340175
[No Abstract] [Full Text] [Related]
29. Comparative study of anticoagulation therapy with an LVAD system.
Takahama T; Kanai F; Hiraishi M; Onishi K; Yamazaki Z; Furuse A; Asano K; Yoshitake T
ASAIO Trans; 1987; 33(3):227-34. PubMed ID: 3118913
[No Abstract] [Full Text] [Related]
30. Comparison of the activities of prostacyclin and its stable analogs on the platelet aggregation and cardiovascular systems.
Kawasaki A; Ishii K; Wakitani K; Tsuboshima M
Adv Prostaglandin Thromboxane Res; 1980; 6():331-6. PubMed ID: 6992531
[No Abstract] [Full Text] [Related]
31. [Possible aspects of the use of prostacyclin, prostaglandin E1 and their synthetic analogs in medical practice].
Petrukhina GN; Makarov VA
Eksp Klin Farmakol; 1995; 58(3):70-9. PubMed ID: 7663307
[No Abstract] [Full Text] [Related]
32. [Clinical study of prostacyclin in extracorporeal circulation. Effects on hemodynamics and coagulation].
Fabiani JN; Bunting S; Terrier E; O'Grady J; Fontaine B; Prigent C; Carpentier A; Vane J; Dubost C
Arch Mal Coeur Vaiss; 1982 Mar; 75(3):241-8. PubMed ID: 6807240
[TBL] [Abstract][Full Text] [Related]
33. Involvement of endogenous prostaglandin I2 in the vascular action of histamine in dogs.
Toda N; Konishi M; Miyazaki M
J Pharmacol Exp Ther; 1982 Oct; 223(1):257-62. PubMed ID: 6750081
[TBL] [Abstract][Full Text] [Related]
34. A new prostacyclin analogue - an anticoagulant applicable to hemodialysis.
Ota K; Kawaguchi H; Takahashi K; Ito K
Trans Am Soc Artif Intern Organs; 1983; 29():419-24. PubMed ID: 6369729
[No Abstract] [Full Text] [Related]
35. Clinical benefit and prolongation of platelet half-life induced by CG 4203, a stable PGI2-analogue.
Kaliman J; Fitscha P; Barth H; Sinzinger H
Prog Clin Biol Res; 1987; 242():469-77. PubMed ID: 3313421
[No Abstract] [Full Text] [Related]
36. Effects of prostacyclin during cardiopulmonary bypass in man.
Rådegran K; Egberg N; Papaconstantinou C
Scand J Thorac Cardiovasc Surg; 1981; 15(3):263-8. PubMed ID: 6753137
[No Abstract] [Full Text] [Related]
37. New prostacyclin analogues.
Bartmann W; Beck G; Knolle J; Rupp RH
Angew Chem Int Ed Engl; 1980; 19(10):819-20. PubMed ID: 6778259
[No Abstract] [Full Text] [Related]
38. Effects of prostacyclin on platelet aggregation as studied with "filter-loop" technique in the flowing blood of the dog.
Imai S; Matsubara I
Artery; 1980; 8(1):63-72. PubMed ID: 7000043
[TBL] [Abstract][Full Text] [Related]
39. Prostacyclin in vascular pathology--therapeutic possibilities.
Gryglewski RJ; Szczeklik A
Ann Clin Res; 1984; 16(5-6):253-61. PubMed ID: 6398663
[No Abstract] [Full Text] [Related]
40. Quantitation of platelet lysis, platelet consumption on oxygenator, and stabilization of platelet membrane with prostacyclin and ibuprofen during cardiopulmonary bypass surgery in dogs.
Dewanjee MK; Vogel SR; Peterson KA; Lim MF; Kaye MP
Trans Am Soc Artif Intern Organs; 1981; 27():197-202. PubMed ID: 7036497
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
